Potential Dilution from the Exercise of Stock Acquisition Rights
First written in FY2018. 7 of 17 entries say "Materialised", first in FY2019-Q1. Latest entry: FY2025.
Bank of Innovation moved to the "Worse" side of this theme in 2019, 2 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
15 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「Not applicable.」
There were no applicable matters concerning the stock option plan, stock acquisition rights, or related matters, confirming that there are no new dilution factors. - FY2024-Q2RestatedAnnual report
「Not applicable.」
There were no applicable matters concerning the stock option plan, other stock acquisition rights, or bonds with stock acquisition rights containing provisions for adjustment of the exercise price, confirming that there are no new dilution factors. - FY2024-Q1RestatedAnnual report
「Not applicable.」
The filing states that there were no applicable matters concerning the stock option plan or other stock acquisition rights, confirming that there are no new dilution factors. - FY2023MitigatedAnnual report
「Decrease due to the acquisition and cancellation of the Ninth and Tenth Series stock acquisition rights with provisions for the adjustment of the exercise price and suspension of exercise 390,200 shares」
The 390,200 Ninth and Tenth Series stock acquisition rights outstanding at the end of the previous consolidated fiscal year were acquired and cancelled, reducing the balance of stock acquisition rights to zero at the end of the current consolidated fiscal year. In addition, 4,000 shares were issued through the exercise of stock options. - FY2023-Q2MaterialisedAnnual report
「1 January 2023–31 March 2023 (Note) 4,000 4,003,000 1 562 1 539 (Note) This increase was due to the exercise of stock acquisition rights (stock options).」
Exercise of stock acquisition rights increased shares issued by 4,000, bringing total shares issued to 4,003,000. The dilution factor materialized through the actual issuance of shares. - FY2023-Q1Increase in shares outstandingAnnual report
「Common shares 3,999,000 3,999,000 Tokyo Stock Exchange (Growth Market)」
Total shares issued were 3,999,000. Although this was an increase from the previously reported 3,951,000 shares, this filing does not provide details of the reason for the increase. - FY2022-Q3RestatedAnnual report
「Total shares issued 3,951,000」
Total shares issued were 3,951,000, with no increase through the exercise of stock acquisition rights during the quarter disclosed. - FY2022-Q1RestatedAnnual report
「Total shares issued 3,951,000」
Total shares issued at the end of the first quarter were 3,951,000, with no increase through the exercise of stock acquisition rights during the quarter disclosed. - FY2021MitigatedAnnual report
「The potential number of shares represented by these stock acquisition rights as of the end of the current consolidated fiscal year was 4,000, equivalent to 0.10% of the total 3,951,000 shares issued.」
Potential shares were 4,000, equivalent to 0.10% of total shares issued, indicating reduced room for dilution compared with previous fiscal years. - FY2021-Q3RestatedAnnual report
「Total shares issued 3,951,000」
Total shares issued at the end of the third quarter were 3,951,000, with no additional increase in the number of shares from the previous quarter disclosed. - FY2020-Q2MaterialisedAnnual report
「1 January 2020–31 March 2020 4,000 3,951,000 2,076 490,943 2,076 468,383 (Note) This increase was due to the exercise of stock options.」
4,000 shares were issued through the exercise of stock options during the quarter, bringing total shares issued to 3,951,000. The dilution factor continued to materialize through the actual issuance of shares. - FY2020-Q1MaterialisedAnnual report
「1 October 2019–31 December 2019 23,000 3,947,000 8,625 488,867 8,625 466,307 (Note) This increase was due to the exercise of stock options.」
Exercise of stock options increased total shares issued by 23,000 during the quarter, and the dilution factor materialized through the actual issuance of shares. - FY2019MaterialisedAnnual report
「The potential number of shares represented by these stock acquisition rights was 38,000, equivalent to 0.97% of the total 3,924,000 shares issued.」
While 28,000 shares were issued through the exercise of stock options during the current fiscal year, potential shares at the end of the period were 38,000 and the dilution rate was 0.97%. - FY2019-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
From April to June 2019, exercise of stock acquisition rights increased total shares issued by 15,000, and the dilution factor continued to materialize through the actual issuance of shares. - FY2019-Q2MaterialisedAnnual report
「This was mainly due to the issuance of new shares upon exercise of stock acquisition rights, which increased both stated capital and the capital surplus by ¥6.747 million, and the recording of quarterly net income of ¥248.944 million.」
The issuance of new shares upon exercise of stock acquisition rights continued to occur in practice, and stated capital and the capital surplus each increased by ¥6.747 million. - FY2019-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
Exercise of stock acquisition rights resulted in a 13,000-share increase in total shares issued during the cumulative period, and the dilution risk materialized through the actual issuance of shares. - FY2018First statedAnnual report
「As of the submission date of this document, the potential number of shares represented by these stock acquisition rights was 53,000, equivalent to 1.36% of the total 3,909,000 shares issued.」
The company disclosed 53,000 potential shares represented by stock acquisition rights, equivalent to 1.36% of total shares issued, and stated the potential for dilution upon exercise.